Upon binding to GLP-1 receptors, GLP-1 RAs activate G-protein signaling pathways, leading to increased cyclic AMP and activation of protein kinase A, which in turn enhances insulin biosynthesis and suppresses glucagon secretion 13,14,15
Oral Wegovy, introduced as the initial GLP-1 pill for weight management, delivers the convenience of daily use with comparable effects to its injectable counterpart
Related Stories Planetary Health Diet lowers cardiovascular risk in older women Dementia addiction and psychiatric disorders show distinct patterns of accelerated brain aging Salk neuroscientists identify traveling brain waves as a computational engine Major challenges in microsphere and microparticle systems include complex, costly manufacturing processes, product variability, and environmental degradation of certain components
Adjustments in insulin therapy may be necessary to prevent recurrent hypoglycemia
Structure-function studies of waglerin I, a lethal peptide from the venom of Waglers pit viper, Trimeresurus wagleri
